Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps.
ACCE opinionRYTHM Inc. Common Stock (RYM)
Fair value
Not available
ACCE price target
$14.05
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $15.69 at the close on 23 Oct 2026, 22:00 CEST.
Models: Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
34
out of 100
P/E
0.0x
forward 0.0x
1-year return
-60.1%
Dividend yield
0.00%
RYTHM Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
RYM is a $40M-market-cap tobacco name whose reported revenue growth of 1,027% and a 75.2% gross margin point to a sharp scale-up from a very small base, but the bottom line has not caught up: ROE sits at -10.5% and operating margin at 8.4%, and with no earnings the P/E is not meaningful. The tailwind is the structural pricing power that comes with smoking-category products, but the data here does not show what is driving the revenue jump, whether it is organic, acquired, or a one-off, so that is the first thing to verify. The score of 36/100 and absence from any index reflect a micro-cap with thin liquidity and limited coverage. It merits a deeper look only if the filings explain the top-line step-up and show a credible path from positive operating margin to positive net income.